IRVINE, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, is ...

“Early detection is one of the most powerful tools we have in vascular medicine,” said Dr. Levison, vascular surgeon at The Cardiovascular Care Group. “The Care Screen gives patients a simple, ...

On the heels of a groundbreaking FDA approval for a major medtech, a Silicon Valley startup is shaping up to be a possible competitor. R3 Vascular recently raised $87 million in venture capital cash ...

The costliness of drug development and the limitations of studying physiological processes in the lab are two separate scientific issues that may share the same solution. Microphysical systems (MPSs) ...